Concepedia

Suresh Aravind

SA

Statistics

Publications

3

Citations

226

H-Index

3

Active since

2009

Affiliations

Johnson & Johnson (United States)(Current)

Suresh Aravind is an author at Johnson & Johnson (United States) specializing in pharmacotherapy, medicine, and pharmaceutical compliance.

Publications per year

2009–2023

3

Publications

3

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: A descriptive study of a large outpatient oncology practice database, 2000–2007

Ying Wu, Suresh Aravind, Gayatri Ranganathan et al. · Clinical Therapeutics · 2009 · 169 citations

Medicine, Hematology, Oncology +14

Impact of illegal trade on the quality of epoetin alfa in Thailand

Fotis Fotiou, Suresh Aravind, Pingping Wang et al. · Clinical Therapeutics · 2009 · 40 citations

Law, Pharmacotherapy, Regulatory Pharmacy +14

Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia

Dean Najarian, Ibrahim Turkoz, R Karl Knight et al. · The International Journal of Neuropsychopharmacology · 2023 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–3 of 3